May 14, 2024 · Form 4 insider transaction
LYONS GARY A bought 12,500 shares of Neurocrine Biosciences, Inc. at $42.76 per share, a transaction worth $534.5K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Reflects a decrease of 76,750 shares from the amount previously reported as beneficially owned, which was recently discovered to be overstated due to an administrative oversight.; 110,964 of the reported shares are held by the Gary A. Lyons Revocable Living Trust U/A 6/8/12, of which the Reporting Person has voting and investment power.